AbbVie Inc. – Filings and Transcripts

NYSE: ABBV
Share price (9/22/26): $265.21
Market cap (9/22/26): $469 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Free writing prospectus

Ownership Filter

Donoghoe Nicholas

Donoghoe Nicholas

Quaggin Susan E

Annual report of employee stock purchase, savings and similar

News Filter

Completes Acquisition of Apogee Therapeutics

Other Events, Financial Statements or Exhibits

Other Events, Financial Statements or Exhibits

Reports Second-Quarter 2026 Financial Results

Guidance Including the Impact of Acquired IPR&D and Milestones Expense

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Conflict Minerals disclosure

Scanned paper annual report submission

Conflict Minerals disclosure

Scanned paper annual report submission

Conflict Minerals disclosure